Skip to content

Outcome After Avascular Necrosis of the Femoral Head in Young Patients

Outcome After Avascular Necrosis of the Femoral Head in Young Patients - Retrospective Analysis With a Min. 10-year Follow-up

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03753282
Acronym
AVN
Enrollment
0
Registered
2018-11-26
Start date
2019-01-30
Completion date
2019-03-05
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis of the Femoral Head

Keywords

Total hip arthroplasty, Total hip replacement

Brief summary

1. The course of AVN between Initial diagnosis and total hip replacement (THA) is analysed. The impact of early interventions versus conservative therapy in AVN before THA will be evaluated. 2. The short and long term outcomes of AVN patients undergoing THA with respect to complications, reoperations and quality of life are investigated. Potential risk factors for adverse outcomes will be investigated.

Detailed description

The study is to describe the course of avascular necrosis (AVN) of the femoral head from initial diagnosis and to collect data on treatment options and the further course in these cases. The duration from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA) will be analysed and the course after joint replacement with potential short- and long-term complications will be evaluated. The impact of THA after AVN on activities of daily living will be assessed by Euroquol 5 Dimensions (EQ-5D-5L) and Hip disability and Osteoarthritis Outcome Score (HOOS) questionnaires.

Interventions

OTHERquestionnaires for patient reported outcome

questionnaires with respect to outcomes: * Reoperations * Short term complications * Long term complications * EQ-5D (current) * HOOS (current) * disease related change of occupation * use of walking aids * comorbidities * medication

OTHERquestionnaire for course of the disease

questionnaires to assess course of the disease: * from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA) * therapeutic interventions

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* MRI of the hip available from diagnosis at the USB or KSBL Liestal * Informed Consent

Exclusion criteria

* Insufficient knowledge of project languages (English, German, French)

Design outcomes

Primary

MeasureTime frameDescription
arthroplasty-free interval (time until THA)single time point assessment at baselinetime from first diagnosis of AVN to joint replacement = time to event data (in the years between 1999-2006)
rate of reoperations after THAsingle time point assessment at baselinereoperation after THA = time to event data (in the years between 2000-2007)

Secondary

MeasureTime frameDescription
Hip disability and Osteoarthritis Outcome Score (HOOS)single time point assessment at baseline40 item questionnaire to assess patient-relevant outcomes in five separate subscales (pain, symptoms, activity of daily living, sport and recreation function and hip related quality of life). Scores are: None, Mild, Moderate, Severe, Extreme
Euroquol 5 Dimensions (EQ-5D-5L)single time point assessment at baselineFive dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026